A small trend for the worst OS in patients with CMV+ was observed for the patients of the old cohort treated by NAC, but did not reach statistical significance, probably because of the small number ( n = 71) of patients in this category ( Figure 6 B).
← all excerpts
CMV seropositivity associates with poor clinical outcome in triple negative breast cancer.
1
—
—